Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci
- PMID: 65433
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci
Abstract
An opsonophagocytic assay has been developed which requires human polymorphonuclear leukocytes, immune serum, and complement for optimal killing of Group B streptococci. Only with all three of these components was killing of greater than 1.0 log10 of the initial inoculum achieved, using rabbit antisera directed to homologous strains of each of the five known serotypes of Group B streptococci. Titers of specific antisera which opsonized the strains and resulted in greater than 1 log 10 reduction of colony-forming units, ranged from 1:100 (serotype Ib) to 1:3200 (serotype Ia). Cross-reactions between serotype-specific sera and heterologous strains were seen in certain instances. Type Ic strain and serotype Ic antiserum demonstrated cross-reactions with types Ia and Ib which were explainable by known shared antigens among these types. The only other cross-reaction which resulted in greater than 1 log 10 reduction in colony-forming units was when unabsorbed antiserum to strain Ia was used to opsonize a strain of serotype III. Opsonization of 10 serotype III strains was demonstrated with a single type III antiserum. Killing of nine of these strains required polymorphonuclear leukocytes, complement, and antiserum, but one strain, D136C, the reference strain, could be killed (greater than 1 log 10 reduction in colony-forming units) without either complement or specific antiserum. Inhibition studies were performed utilizing large m.w. polysaccharide antigens extracted from each serotype. These antigens inhibited opsonization of homologous strains by homologous antisera with 50% inhibition points ranging between 0.5 and 4 mug.
Similar articles
-
Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.J Clin Invest. 1976 Dec;58(6):1379-87. doi: 10.1172/JCI108593. J Clin Invest. 1976. PMID: 62761 Free PMC article.
-
Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.Microb Pathog. 1994 May;16(5):359-72. doi: 10.1006/mpat.1994.1036. Microb Pathog. 1994. PMID: 7815919
-
Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.J Immunol. 1985 Dec;135(6):4164-70. J Immunol. 1985. PMID: 3934276
-
Surface-localized protein antigens of group B streptococci.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S363-6. doi: 10.1093/cid/10.supplement_2.s363. Rev Infect Dis. 1988. PMID: 3055205 Review.
-
Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae.Clin Vaccine Immunol. 2015 Feb;22(2):153-9. doi: 10.1128/CVI.00643-14. Epub 2014 Dec 24. Clin Vaccine Immunol. 2015. PMID: 25540270 Free PMC article. Review.
Cited by
-
Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8317-21. doi: 10.1073/pnas.88.19.8317. Proc Natl Acad Sci U S A. 1991. PMID: 1656437 Free PMC article.
-
Group B streptococcal long-chain reaction.Infect Immun. 1977 Dec;18(3):666-72. doi: 10.1128/iai.18.3.666-672.1977. Infect Immun. 1977. PMID: 338488 Free PMC article.
-
Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection.J Clin Invest. 1977 Nov;60(5):1149-58. doi: 10.1172/JCI108867. J Clin Invest. 1977. PMID: 409733 Free PMC article.
-
Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.Infect Immun. 1992 Nov;60(11):4801-8. doi: 10.1128/iai.60.11.4801-4808.1992. Infect Immun. 1992. PMID: 1398991 Free PMC article.
-
Murine resistance to type III group B streptococci.Infection. 1980;8(2):54-7. doi: 10.1007/BF01639146. Infection. 1980. PMID: 6993364
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources